ICU Medical Gets FDA Clearance for Clave
ICU Medical Inc. announced that the U.S. Food and Drug Administration has granted 510(k) clearance for its Clave portfolio of needlefree IV connectors. The clearance is based on peer‑reviewed evidence that hospitals using Clave technology achieve greater infection reduction and cost savings compared to non‑Clave hospitals. The announcement was made in San Clemente, California on September 18, 2025.